SureTrader SureTrader
Home > Boards > US Listed > Miscellaneous >

MiMedx Group, Inc. (MDXG)

MDXG RSS Feed
Add MDXG Price Alert      Hide Sticky   Hide Intro
Moderator:
Search This Board:
Last Post: 9/6/2016 9:00:34 PM - Followers: 17 - Board type: Free - Posts Today: 0

 



           
 





Feb 2013 Investor Presentation:

http://www.mimedx.com/media/pdf/MDXG%20Investor%20presentation%20020213.pdf




Investor Introduction:

About MiMedx

MiMedx® is an integrated developer, manufacturer and marketer of patent protected regenerative biomaterial products processed from human amniotic membrane.

"Innovations in Regenerative Biomaterials" is the framework behind our mission to give physicians products and tissues to help the body heal itself. Our biomaterial platform technologies include the device technologies HydroFix® and CollaFix™, and tissue technologies, AmnioFix® and EpiFix®. Our tissue technologies are processed from human amniotic membrane that is derived from the donated placentas. Through our donor program, mothers delivering full-term Caesarian births can elect in advance of delivery to donate the placenta in lieu of having it discarded as medical waste. We process the human amniotic membrane utilizing our proprietary PURION® Process to produce a safe, effective and minimally manipulated implant for homologous use. MiMedx® is the leading supplier of amniotic tissue, having supplied over 100,000 implants to date to distributors and OEMs for applications in the Ophthalmic, Orthopedic, Spine, Wound Care, and Dental sectors of healthcare.

Our platform technologies, AmnioFix®, EpiFix®, HydroFix® and CollaFix™, have such a vast number of potential applications in treating traumatized tissue and structures that it is difficult to accurately quantify. MiMedx Group is focused on commercializing multiple applications of all four technologies. In parallel, we are seeking strategic relationships to more rapidly commercialize our technologies.
AmnioFix®, EpiFix®, HydroFix®and CollaFix™are trademarks of MiMedx Group, Inc.

 

Contact and Stock Information

MiMedx Group, Inc.
60 Chastain Center Boulevard
Suite 60
Kennesaw, GA 30144

Phone: 678-384-6720
Website: http://www.mimedx.com

Estimated Market Cap : $286.26M as of Dec 18, 2012

Outstanding Shares 86.7M as of December 18, 2012

Float: 66.68M as of December 18, 2012

Parker H. "Pete" Petit - Chairman of the Board and Chief Executive

Mr. Petit was Chairman and CEO of Matria Healthcare which was sold to Inverness Medical Innovations in May of 2008. Matria Healthcare was a former subsidiary of Healthdyne, which Mr. Petit founded in 1970. Mr. Petit served as Chairman and CEO of Healthdyne and several of its publicly traded subsidiaries after Healthdyne became a publicly traded company in 1981. One of Healthdyne's other subsidiaries, Healthdyne Technologies, was merged with Respironics in 1995, and Respironics was sold in 2008 to Phillips Healthcare.

Mr. Petit received his Bachelor's degree in Mechanical Engineering and Master of Science degree in Engineering Mechanics from Georgia Institute of Technology and an MBA degree in Finance from Georgia State University. At Georgia Tech, Mr. Petit funded a professorial chair for "Engineering in Medicine", endowed the Petit Institute for Bioengineering and Bioscience, and assisted with the funding of the Biotechnology Building which bears his name. At Georgia State University, he assisted with the funding of the Science Center building which also bears his name. In 1994, he was inducted into the Technology Hall of Fame of Georgia. In 2007, he was inducted into the Georgia State Business School Hall of Fame. Mr. Petit has previously served as a member of the Board of Directors of the Georgia Research Alliance which is chartered by the State of Georgia to promote high technology and scientific development in the State. He has also previously served on several public company Boards of Directors.


Board of Directors       

Steve Gorlin  • Founder of MiMedx Group, Inc. • Founder of several biotechnology/pharmaceutical companies, including HycorBiomedical, Theragenics(NYSE:TGX), CytRx(Nasdaq:CYTR), MedicisPharmaceutical (NYSE:MRX), EntreMed(Nasdaq:ENMD), Surgi-Vision, DARA BioSciences, (Nasdaq:DARA), SpineMedica and Medivation(Nasdaq: MDVN)       

Charles Koob  • Successful M&A, Anti-trust, Corporate attorney at Simpson Thatcher and Bartlett • Experience includes the defense of Appleton Papers, representation of Virgin Atlantic Airways, and the representation of a special committee of Archr Daniels Midland in a federal grand jury investigation of price-fixing       

Larry Papasan  • Venture Partner at MB Venture Partners • Former President of Smith & Nephew Orthopedics • Chairman at BioMimetic Therapeutics (Nasdaq:BMTI), Board Member at Memphis Biotech Group and Plough Foundation • Chairman at Lebonheur Children's Hospital Foundation, Pres. of the Board at the Biblical Resource Center & Museum       

Joseph G. Bleser  • Experienced Healthcare Exec, CFO, Board member, Audit Chair • Over 20 years as CFO of Public Healthcare & Technology companies • Companies include: HBO, Healthdyne Information Enterprises, Allegiant Physician Svs, Healthcare.com, Transcend Services • BOD: Transcend Services (NASDAQ: TRCR), Matria Healthcare • Licensed CPA with 10 yrs public accounting for international firm       

Terry Dewberry  • Experienced Healthcare Exec, Board member, Audit Chair • Previously Director of Respironics, and Matria Healthcare • Currently on Board of DrTango, a private multicultural communications and health management company • Previously, Director, Vice Chairman, President and COO, and CFO of Healthdyne, 1981 -1996 • Experience buy & sell side Corp M&A, transactions up to $5 billion


 


AmnioFix® is a dehydrated human amniotic membrane processed through Surgical Biologic's proprietary Purion®process, which combines cleaning, dehydration and sterilization to produce a safe, technically sterilized tissue allowing for storage at room temperature.AmnioFix® is processed from human tissue according to the American Association of Tissue Banks (AATB) standards, and is considered a tissue product under Section 361 of the Public Health Service Act. This means that AmnioFix® is regulated differently than the other two MiMedx platform technologies, CollaFix™ and HydroFix®, which are regulated as medical devices and therefore need FDA clearances prior to marketing in the United States. Since it is regulated as a tissue product, AmnioFix® does not need such clearance or approval in the United States.

Injectable Micronized Amniotic Membrane Allograft for Enhanced Soft Tissue Healing

AmnioFix® Injectable is composed of a micronized dehydrated amniotic membrane that provides essential growth factors for enhanced soft tissue healing.
Delivers Essential Growth Factors and Extracellular Matrix Proteins Like Collagen
Reduces Inflammation
Enhances Healing
Injectable Formulation for Easy Application into Deep Soft Tissues
Stores at Room Temperature for up to 5 Years
Available in 3 sizes (0.5cc, 1.25cc, 2.0cc)

Applications for AmnioFix Injectable include:

Tendonitis (inflamed tendon such as "tennis or golfers elbow")
Other Inflamed Soft Tissues Such as Bursitis and Fasciitis

Muscle Sprains
Around the Periphery of a Chronic Ulcer or Burn
Long/Deep Surgical Incisions




EpiFix® is a biologic Human Amniotic Membrane processed through Surgical Biologic's proprietary Purion®process, which combines cleaning, dehydration and sterilization to produce a safe, technically sterilized tissue allowing for storage at room temperature.  EpiFix® is processed from Human tissue according to the American Association of Tissue Banks (AATB) standards, and is considered a tissue product under Section 361 of the Public Health Service Act. This means that EpiFix® is regulated differently than the other two MiMedx platform technologies, CollaFix™ and HydroFix®, which are regulated as Medical Devices and therefore need FDA clearances prior to marketing in the United States. Since it is regulated as a Tissue product, EpiFix® does not need such clearance or approval in the United States.

The New Foundation for Tissue Regeneration
An Amniotic Membrane Allograft for  Chronic and Acute Wound Healing

Delivers Essential Wound Healing Growth Factors
Enhance Healing
Reduces Inflammation and Scar Tissue Formation
Stores at Room Temperature for up to 5 Years
Available in 4 sizes
Growth factors present in EpiFix®*:

Epidermal Growth Factor (EGF)
Promotes proliferation of epithelial cells
Transforming Growth Factor - β (TGF-β)
Anti-inflammatory, and promotes normal wound healing and reduced scar formation
Fibroblast Growth Factor (FGF)
Promotes cellular proliferation & important for collagen matrix formation
Platelet Derived Growth Factor A & B (PDGF A & B)
Promotes cell proliferation in connective tissue & enhances soft tissue healing



 

                  MIMEDX PHYSICIAN ADVISORY BOARD   James Andrews, MD - Chairman 
                   Leon E Paulos, MD 
                   Neal Elattrache, MD 
                   Timothy Kremchek, MD 
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
MDXG
Current Price
Volume:
Bid Ask Day's Range
SureTrader
PostSubject
#162   Just caught your post from a few months back. growtheport 09/06/16 09:00:34 PM
#161   Undervalued. Been building a position in the growtheport 09/06/16 08:46:29 PM
#160   Both the last quarterly calls were good imo. bleedpurple 07/30/16 01:19:43 PM
#158   Nice 2Q revenue beat by $MDXG. Between this, jones99 07/12/16 03:35:18 AM
#157   So quiet here on this board. Anyways thighs Betchips 05/23/16 11:00:21 AM
#156   Nice close yesterday. Betchips 05/21/16 11:40:00 AM
#155   I read the shareholder letter. Looks like they Betchips 05/20/16 09:25:36 AM
#154   Yeah. I've been buying under 7. I'm capitalkid 05/20/16 09:22:52 AM
#153   You still in? Seems like a good purchase Betchips 05/20/16 09:04:06 AM
#152   Looks like the bottom is in and good Betchips 05/17/16 02:10:05 PM
#151   Great fundamentals here in a virtually wide-open space. mitcheroo 05/17/16 09:32:49 AM
#150   Now it's at @ 8.18 swingingRichard 03/15/16 10:47:40 PM
#149   Quiet here Betchips 02/25/16 09:42:28 PM
#148   Now it is @ 9.00... :) dog turd cannon 11/30/15 11:56:02 AM
#147   Should have sold today when I was up swingingRichard 10/30/15 10:38:31 PM
#146   Thanks for the reply. Yes I learned bleedpurple 07/14/15 04:17:52 PM
#145   Heh, welcome aboard. I will say that I've often capitalkid 07/14/15 03:16:38 PM
#144   I think we will find out soon regarding capitalkid 07/14/15 03:13:45 PM
#143   Capital kid, I couldn't take it had to bleedpurple 07/13/15 12:40:28 PM
#142   I have of course read their website and bleedpurple 07/13/15 12:23:35 PM
#141   Nice run you've had and are having! bleedpurple 07/13/15 12:22:36 PM
#140   The yahoo boards are active, for whatever reason capitalkid 07/13/15 11:46:06 AM
#139   New to the board. I see it bleedpurple 07/13/15 10:20:34 AM
#138   Stock is climbing and this board is dead...? Spudskie 02/20/15 11:11:07 AM
#137   A lot of news, yet this stock is MikeBK205 01/06/15 02:48:57 PM
#136   MDXG: the stock has moved nicely in the FreeNorth 11/03/14 12:05:46 PM
#135   $MDXG DD Notes ~ http://www.ddnotesmaker.com/MDXG stocktrademan 10/26/14 11:19:18 AM
#134   SikBoof, Sorry, I missed your message. Regarding Epifix strut1702 09/27/14 05:11:38 PM
#133   Hey Strut, SikBoof 06/05/14 10:19:23 AM
#132   Is this board alive? We now have strut1702 03/14/14 10:58:37 PM
#131   Nice numbers from the MDXG boys in Marietta Roogie 02/26/14 08:51:10 AM
#130   holy crap….. it kept going. Immie 12/29/13 12:40:44 PM
#129   very smart! [SMART MONEY] 12/12/13 06:19:24 PM
#128   Smart; And medicare reimbursement news released at same time mlkrborn 12/12/13 01:11:08 PM
#127   Both medicare reimbursement and secondary offer @ $6.80 mlkrborn 12/12/13 01:09:03 PM
#126   MiMedx Prices $34.0 Million Public Offering of Common [SMART MONEY] 12/12/13 08:51:50 AM
#125   good resuts $5.83 "MiMedx Group follow up mlkrborn 11/19/13 05:29:10 PM
#124   MiMedx Group reports on meeting with FDA (5.49 biocqr 10/29/13 10:33:38 AM
#123   MARIETTA, Ga., Oct. 1, 2013 /PRNewswire/ -- MiMedx AtlasSnuggled 10/01/13 08:48:14 AM
#122   MiMedx&Medtronic sign distribution deal for Purion products AtlasSnuggled 10/01/13 08:24:22 AM
#121   CEO states that "MiMedx has many of the ECole 09/06/13 05:27:31 AM
#120   Company response AtlasSnuggled 09/04/13 05:32:46 PM
#119   Untitled letter per FDA AtlasSnuggled 09/04/13 05:31:36 PM
#118   MiMedx Announces Record Second Quarter Results biocqr 08/01/13 11:54:40 AM
#117   9:02AM MiMedx Group crossover study is published in biocqr 07/31/13 10:32:11 AM
#116   MiMedx: An Opportunity To Come On Board biocqr 07/22/13 07:06:59 PM
#115   MiMedx Group receives additional EpiFix Medicare reimbursement coverage mlkrborn 06/28/13 11:10:31 AM
#114   this thing has had one hell of a arnieshell 06/22/13 05:30:07 PM
#113   MiMedx Group announces receipt of three newly issued biocqr 06/11/13 12:01:39 PM
#112   This is what insurers were waiting for to biocqr 06/10/13 11:19:07 PM
PostSubject